Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review.

Hiba El Masri Treasure M McGuire Mieke L van Driel Helen Benham Samantha A Hollingworth

Published in: Patient preference and adherence (2022)

Factors important for patients' BRA of their medicines during a chronic disease journey vary more with their clinical situation and previous treatment experience than with time since diagnosis. Due to the importance of these factors on patients' perspectives and potential impact on their decision-making and eventually their clinical outcomes, there is a need for more studies to assess the dynamics of patients' BRA in every disease.

Keyphrases

end stage renal disease
risk assessment
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
decision making
patient reported outcomes
heavy metals
climate change
combination therapy